METHODOLOGICAL MATERIALS

Practical principles of using LUGELA in medical and rehabilitative practice

The methodological materials of LUGELA combine practical recommendations based on the results of scientific, experimental, and clinical studies of the medicinal mineral water LUGELA.

Their purpose is to help doctors and specialists move from general scientific information about the properties of LUGELA to the consistent application of the natural mineral complex, taking into account specific diseases, patient condition, and therapeutic or rehabilitative goals.

Basic principle of application

LUGELA is a natural highly mineralized medicinal water and is used in measured doses, in courses, considering the nature of the pathological process.

The main methodological sequence:

CLINICAL ASSESSMENT → PURPOSE OF USE → REGIMEN OF INTAKE → COMPLEX THERAPY → RESULT CONTROL

This approach allows the use of LUGELA not by a single universal scheme, but according to the specifics of a particular medical direction.

Basic internal usage regimen

Shake the bottle well before each use.

Adults
Take 10 ml of LUGELA 3 times a day after meals.
Intervals between doses should be at least 5 hours.
A single dose should not exceed 10 ml.

Standard monthly course: 4 bottles of LUGELA.
Children from 3 to 9 years old
Take 5 ml of LUGELA 3 times a day after meals.
Intervals between doses should be at least 5 hours.

Standard monthly course: 2 bottles of LUGELA.

Children under 3 years old. A single dose is 3 drops of LUGELA diluted in water or food and taken during feeding. The frequency and duration of the course for infants and young children are determined individually.

In the standard regimen, LUGELA is taken undiluted. After administration, drink 40–50 ml of warm drinking water.

The standard course duration is 30 days. Repeat courses or dosage changes are determined individually.

Time of intake

Standard regimen. LUGELA is taken after meals in the established age dosage.

It is recommended to drink 1–2 glasses of warm drinking water 30 minutes before breakfast, lunch, and dinner.

After meals, take the established dose of LUGELA and drink 40–50 ml of warm drinking water.

For stomach and duodenal diseases.

For gastritis, stomach ulcer, and duodenal ulcer, the time of intake and dilution degree of LUGELA are determined considering diagnosis, acidity, and disease period.

Specialized pre-meal regimens are provided in the "Digestive system" section of the current instructions.

Differentiated use

Inflammatory diseases

In conditions accompanied by inflammatory reactions, LUGELA is used as a component of complex therapy taking into account the studied anti-inflammatory properties of the natural mineral complex.

The evaluation of results considers:

  • severity of inflammation;
  • clinical symptoms;
  • functional state of the affected organ;
  • dynamics of laboratory parameters.

Allergic and exudative conditions

In allergic diseases and conditions with increased vascular-tissue permeability, LUGELA usage is based on its desensitizing effects and influence on inflammatory-exudative processes.

Mineral metabolism disorders

In conditions related to calcium and general mineral metabolism, LUGELA is used as a natural highly mineralized complex.

Depending on the clinical task, the doctor assesses:

  • calcium metabolism;
  • electrolyte balance;
  • kidney function;
  • bone tissue state;
  • endocrine factors of mineral metabolism.

Digestive system diseases

In gastritis, ulcers, liver diseases, biliary tract disorders, and other digestive problems, the following are considered:

  • mucous membrane state;
  • nature of the disease;
  • functional state of the gastrointestinal tract;
  • timing of LUGELA intake relative to meals.

For stomach and duodenal diseases, time and dilution are individually determined based on diagnosis, acidity, and disease stage.

Skin diseases

For eczema, psoriasis, neurodermatitis, and other inflammatory skin diseases, the internal course of LUGELA can be combined with external use.

Used methods include:

  • local treatment;
  • applications;
  • other recommended external application methods.

Clinical dynamics are assessed by skin condition, inflammation and itch severity, lesion area, and skin barrier restoration.

Musculoskeletal system

For fractures, osteoporosis, arthritis, arthrosis, and post-traumatic rehabilitation, LUGELA is included in the complex program as a source of natural mineral complex.

Monitored parameters include:

  • bone tissue condition;
  • mineral metabolism;
  • restoration of motor function;
  • inflammation dynamics;
  • rehabilitation results.

Excretory system

For kidney and urinary tract diseases, use is carried out considering:

  • kidney excretory function;
  • diuresis;
  • urine parameters;
  • status of electrolyte and mineral metabolism.

In cases of significant kidney function impairment, regimen and fluid load are individually determined based on diagnosis and laboratory results.

Proctological diseases

For proctitis and hemorrhoids, LUGELA is used internally as part of complex therapy.

For paraproctitis, LUGELA is included in the rehabilitation program after the main treatment strategy is defined.

Special rectal application methods are not part of the general drinking instructions and require separate specialized methodology.

External use

Scientific, clinical, and methodological materials describe the external use of LUGELA:

  • for rinsing mouth and throat;
  • for skin treatment;
  • for local applications;
  • for treating inflamed and damaged areas;
  • for mucous membrane treatment following specialized methodology.

External use may be combined with internal course intake of LUGELA.

The specific method, concentration, duration, and frequency of external use are determined by the relevant direction and described in the specialized article.

Special ophthalmic, gynecological, urological, and rectal methods are not included in the general drinking instructions and are used only when a separate specialized methodology is available.

Combination with complex therapy

LUGELA is used together with the necessary specialized therapy. Having a confirmed diagnosis does not cancel the therapy prescribed by the doctor when using LUGELA.

Depending on the diagnosis, the following may be used:

  • anti-inflammatory agents;
  • antibacterial therapy;
  • antiviral therapy;
  • endocrinological treatment;
  • gastroenterological therapy;
  • dermatological treatment;
  • surgical methods;
  • physiotherapy;
  • rehabilitation programs.

The goal of LUGELA usage is defined by the leading physiological and pathological mechanisms of the specific disease.

Effectiveness control

The course result is evaluated based on clinical and objective dynamics.

Monitored parameters include:

  • severity of main symptoms;
  • activity of the inflammatory process;
  • functional state of the corresponding organ or system;
  • laboratory indicators;
  • mineral metabolism condition;
  • tissue recovery;
  • course tolerability;
  • stability of the achieved result.

Regimen and nutrition

To maintain water-salt balance and comply with the established course regimen, it is recommended to:

  • drink 1–2 glasses of warm drinking water 30 minutes before breakfast, lunch, and dinner;
  • take LUGELA in the established dosage after meals and drink 40–50 ml of warm water;
  • avoid food and other drinks for 1–1.5 hours after intake;
  • then drink at least 200 ml of warm drinking water;
  • maintain sufficient fluid intake throughout the day.

For heart diseases, kidney diseases, tendency to edema, or established fluid restriction, the daily fluid volume is determined individually.

During the course, it is recommended to:

  • limit added sugars and sugar-containing products;
  • limit yeast pastries;
  • limit industrial dairy products with high sugar and food additives content;
  • reduce consumption of refined oils, fried, and excessively fatty foods;
  • include vegetables, greens, fruits, and other natural products in the diet;
  • avoid overeating;
  • follow an individual therapeutic diet if prescribed by a specialist.

Balanced nutrition and adequate fluid intake are part of the overall LUGELA application course.

Do not independently increase the established dosage.

Contraindications and special conditions

According to the current instructions, contraindications for using LUGELA are:

  • hypercalcemia;
  • individual intolerance to the components of the natural mineral composition.

If hypercalcemia or individual intolerance is present, LUGELA is not used.

In cases of significant kidney function impairment, calcium, mineral, or electrolyte metabolism disorders, the regimen and fluid load are determined individually.

Practical algorithm for specialists

  1. Conduct a clinical assessment of the patient's condition.
  2. Identify the leading pathological process.
  3. Formulate the specific purpose of LUGELA use.
  4. Select the appropriate regimen and course duration.
  5. Coordinate use with the primary therapy.
  6. Determine objective control indicators.
  7. Evaluate dynamics after the course.
  8. Decide on the need for repeated or maintenance use.

Conclusion

The methodological materials of LUGELA form a unified practical principle for the application of natural medicinal mineral water:

SCIENTIFICALLY PROVEN PROPERTY → SPECIFIC CLINICAL TASK → DOSED APPLICATION → OBJECTIVE RESULT CONTROL

This approach allows the consistent use of accumulated scientific and clinical data of LUGELA in practical medical and rehabilitative work.

↓
Proceed to scientific materials
Lugela Science Library Free consultation Register Back